Nabla Bio
Cambridge
About Nabla Bio
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $37.4M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2024)
- Website: nabla.bio
- Phone: http://[email protected]
Industries & Categories
Biopharma, Biotechnology, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/nabla-bio-62640 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.